Literature DB >> 2154969

Cholera toxin modulation of angiotensin II-stimulated inositol phosphate production in cultured vascular smooth muscle cells.

L Socorro1, R W Alexander, K K Griendling.   

Abstract

Activation of phospholipase C by angiotensin II in vascular smooth muscle has been postulated to be mediated by an unidentified GTP-binding protein (G-protein). Using a permeabilized preparation of myo-[3H]inositol-labelled cultured vascular smooth muscle cells, we examined the ability of a non-hydrolysable analogue of GTP, guanosine 5'-[gamma-thio]triphosphate (GTP[S]), to stimulate inositol phosphate formation. GTP[S] (5 min exposure) stimulated inositol polyphosphate release by up to 3.8-fold in a dose-dependent manner, with an EC50 (concn. producing half-maximal stimulation) of approx. 50 microM. Inositol bisphosphate (IP2) and inositol trisphosphate (IP3) accumulations were also stimulated by NaF (5-20 mM). Furthermore, angiotensin II-induced inositol phosphate formation could be potentiated by a submaximal concentration of GTP[S] (10 microM), and this treatment appeared to interfere with the normal termination mechanism of the initial hormonal signal. The G-protein mediating angiotensin II-stimulated phospholipase C activation was insensitive to pertussis toxin at an exposure time and concentration which were sufficient to completely ADP-ribosylate all available substrate (100 ng/ml, 16 h). In contrast, a similar incubation with cholera toxin markedly inhibited angiotensin II-stimulated IP2 and IP3 release by 67 +/- 6% and 62 +/- 6% respectively. Cholera toxin appeared to inhibit angiotensin II stimulation of phospholipase C by a dual mechanism: it caused a 45% decrease in angiotensin II receptor number, and also inhibited G-protein transduction as assessed by GTP[S]-stimulated IP2 formation. This latter inhibition may be secondary to an increase in cyclic AMP, since it could be simulated by addition of dibutyryl cyclic AMP. Thus angiotensin II-stimulated inositol phosphate formation is cholera-toxin-sensitive, and is mediated by a pertussis-toxin-insensitive G-protein, which may be involved directly in termination of early signal generation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154969      PMCID: PMC1133703          DOI: 10.1042/bj2650799

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Islet activating protein inhibits kinin-stimulated inositol phosphate production, calcium mobilization, and prostaglandin E2 synthesis in renal papillary collecting tubule cells independent of cyclic AMP.

Authors:  J A Shayman; J J Morrissey; A R Morrison
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

Review 2.  Receptor-phosphoinositidase C coupling. Multiple G-proteins?

Authors:  W W Lo; J Hughes
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

Review 3.  Receptors and phosphoinositide-generated second messengers.

Authors:  L E Hokin
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase.

Authors:  E J Neer; J M Lok; L G Wolf
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

6.  Sodium, divalent cations, and guanine nucleotides regulate the affinity of the rat mesenteric artery angiotensin II receptor.

Authors:  G B Wright; R W Alexander; L S Ekstein; M A Gimbrone
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

7.  Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle.

Authors:  R W Alexander; T A Brock; M A Gimbrone; S E Rittenhouse
Journal:  Hypertension       Date:  1985 May-Jun       Impact factor: 10.190

8.  Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  Hypertension       Date:  1985 Jan-Feb       Impact factor: 10.190

9.  Evidence for tight coupling of thyrotropin-releasing hormone receptors to stimulated inositol trisphosphate formation in rat pituitary cells.

Authors:  A Imai; M C Gershengorn
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

10.  Functional angiotensin II receptors in cultured vascular smooth muscle cells.

Authors:  S Gunther; R W Alexander; W J Atkinson; M A Gimbrone
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  4 in total

1.  G-Protein binding domains of the angiotensin II AT1A receptors mapped with synthetic peptides selected from the receptor sequence.

Authors:  H Kai; R W Alexander; M Ushio-Fukai; P R Lyons; M Akers; K K Griendling
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

2.  The effect of cyclic AMP elevating agents on bradykinin- and carbachol-induced signal transduction in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; H C Hsia; S F Luo; J T Hsieh; R Ong
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  Potentiation by cholera toxin of bradykinin-induced inositol phosphate production in the osteoblast-like cell line MC3T3-E1.

Authors:  Y Banno; T Sakai; T Kumada; Y Nozawa
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

4.  Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.

Authors:  M Campos-Toimil; T Keravis; F Orallo; K Takeda; C Lugnier
Journal:  Br J Pharmacol       Date:  2008-03-03       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.